|
|
|
|
Hi ,
|
This week’s digest is brought to you by Woodside Energy, a global energy company founded in Australia that provides the energy the world needs to heat and cool homes, keep lights on, and enable industry.
|
Meet the Latest SynBioBeta Speakers!
|
|
|
New SynBioBeta 2024 Sponsors & Exhibitors:
|
Shiru uses AI, bioinformatics, and precision biology to discover and produce high-value ingredients.
ClutchBio takes care of the complex task of cloning by providing plasmid design software and building reusable DNA toolkits for plasmid construction, enabling fast turnaround times and reduced cost.
LanzaTech takes carbon capture a step further by transforming it into something valuable and useful at scale. This technology directly replaces virgin fossil carbon in consumer goods and sustainable aviation fuel.
Kura Biotech develops superior enzymatic tools to streamline sample preparation workflows, enabling scientists to overcome life science challenges.
Orbillion is a B2B cultivated meat technology company that brings commercially viable meat to the ever-growing $211 billion global ground beef market.
Fermelanta creates a novel industrial revolution in the production of plant-based chemicals through microbial fermentation by synthetic biology.
BIOMILQ is a woman-owned and science-led biotech startup developing novel technology to make human milk components outside the body.
Bold View Capital is a well-established asset financing provider that has activated $1B worth of financing and leasing programs for over 30 years.
Gene Universal is a pioneer in gene synthesis, genomics research, and applied biological technology.
INTEGRA provides user-friendly solutions for Liquid Handling and Media Preparation applications, serving the needs of its customers in research, diagnostics, and quality control laboratories.
Limited spaces on the exhibit hall floor are still available; contact Anissa Cooke to grab one.
|
|
|
|
|
Now available on-demand!
|
Watch Dr. George Church and Dr. David Baker's interactive Town Hall focused on the intersection of AI and protein design. Moderated by Dr. Sarah Carter, you’ll discover how generative AI is revolutionizing the field of biology, enabling unprecedented advancements in human health, planetary health, and beyond. Click here to watch.
|
Don’t miss the opportunity to join the Invert Bio 2024 Mixer
|
|
Thanks to our New 2024 Event Partners:
|
SynBioBR, Allbiotech, GASB (German Association for Synthetic Biology), CCiC (Conference of China iGEMer Community), iGEM, Nucleate, Great Lakes SynBio Association.
|
Who Just Signed up to Join Us at SynBioBeta?
|
RTX BBN, North Carolina Biotechnology Center, TeselaGen, ADM, Becoming Bio, Evonetix, Twist Bioscience, Biodesign Challenge, Thermo Fisher Scientific, Stemloop, The Life Robotic, Molecular Devices, BASF, Wilson Sonsini, Research Corporation Technologies, Innovate UK Business Growth, Messaginglab, Empress Therapeutics Queensland Government, University of Edinburgh, and Kura Biotech.
|
Is Your Company Hiring?
|
We’ll have a special bioeconomy jobs board in the exhibit hall at SynBioBeta 2024. If your company is hiring and you’d like your job listed, please send the description to info@synbiobeta.com before Friday, April 26. We’ll also include your job posting for free on the SynBioBeta website and in our special conference jobs digest.
|
Register now
|
|
|
|
|
Insights (Exclusive Content):
|
|
|
|
Industry News:
|
|
Additional Industry News:
|
Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editor. OpenCRISPR-1 is publicly available and free to license for ethical research and commercial use. (Press
release)
Generative A.I. Arrives in the Gene Editing World of CRISPR: Much as ChatGPT generates poetry, a new A.I. system devises blueprints for microscopic mechanisms that can edit your DNA (New York Times)
In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D. A star-studded mix of venture capitalists and scientists, backed by more than a billion dollars, is launching an ambitious biotech that aims to reinvent drug R&D using artificial intelligence (Endpoints News)
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine. SNIPR001 into clinical trials in hematological cancer patients (SNIPR Biome)
SOSV founder says climate investing is a ‘war effort’ as firm closes $306M fund: “This is really a war effort. We have to stop pretending this is just another investment theme of the day. This is an existential crisis for the planet,” Sean O’Sullivan said. (TechCrunch)
This Harvard spinoff uses plastic-eating microbes to clean up waste. There are 5 billion tons of plastic sitting in landfills and in nature. This startup is working on a new way to clean it up using biology. (Fast Company)
Pili has successfully industrialized a biobased aniline derivative to decarbonize the chemical industry: The company has produced several tons of a 100% biobased aromatic compound via a robust and reproducible industrial process.
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing (Press release)
Molecular farming startup Nobell Foods rebrands as Alpine Bio, secures 10th US patent. Founded by Magi Richani in 2016 as Alpine Roads, the San Francisco-based company still plans to launch cheeses featuring its animal-free casein under the Nobell Foods brand (AgFunder News)
Sofinnova Partners appoints two new partners, strengthening team of next-generation investors: Guillaume Baxter, a Principal on the Industrial Biotech Strategy, has been promoted to Partner.
Join BioWell's Inaugural Cohort: Seize Your Opportunity to Lead in Bioindustrial Innovation. BioWell is excited to invite you to join our first cohort. Their mission? To help kickstart innovative ventures like yours and push them to the forefront of the bioindustrial world.
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership. The company also announced that Todd R. Nelson will no longer be the Company’s CEO and will transition to a board-only role. (Press release)
The OECD just launched a Neurotech Responsible Innovation Toolkit to support policymakers in implementing the OECD Recommendation on Responsible Innovation in Neurotechnology. You can also learn more at SynBioBeta 2024.
That’s all the news that’s fit to email! SynBioBeta is just two weeks away, and I can’t wait to see you there! Pre-show pricing on conference passes and hotel rooms ends this Friday (4/26!) Register today
Regards
John
|
Who's hiring?
|
R&D Director at Neoplants (Léonce Basset, Saint-Ouen, France)
Research Associate II, Downstream Processing at Antheia (Menlo Park, CA)
Chief Technology Officer (CTO) at Cauldron (Australia)
Senior Software Engineer, Full Stack at Matterworks (Somerville, MA)
Senior Data Engineer, Full Stack at Matterworks (Somerville, MA)
Senior Scientist/Scientist at Matterworks (Somerville, MA)
Associate Director, RNA Purification & Characterization at Ginkgo Bioworks (MA, United States)
Staff Process Engineer at Twist Bioscience (South San Francisco, CA)
|
|
|
|
|
|
|